Novel fatty acid-binding protein 3 ligand... - Cure Parkinson's
Novel fatty acid-binding protein 3 ligand inhibits dopaminergic neuronal death and improves motor and cognitive impairments in Parkinson's
![Farooqji profile image](https://images.hu-production.be/avatars/d2bcede6695608a9d172b4c00f6b376c_small@2x_100x100.jpg)
Written by
![Farooqji profile image](https://images.hu-production.be/avatars/d2bcede6695608a9d172b4c00f6b376c_small@2x_100x100.jpg)
Farooqji
To view profiles and participate in discussions please or .
4 Replies
•
I don't have access to the full article. The abstract only gives the general chemical category for MF8, and an internet search brings up cubic puzzles. How do we identify MF8, and have they started clinical trials? Is it considered a supplement or pharmaceutical?
"Recently, we have developed MF8..." Means it is a proprietary molecule not available to the general public.
If anyone wants to contact the author of the paper, here is the email address
Kfukunaga@m.tohoku.ac.jp